NICE UPDATES MANAGEMENT GUIDELINES FOR NEW CORONARY VIRAL INFECTIONS WITH UNDERLYING DISEASES
-
Last Update: 2020-05-29
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The National Institute for Health and Care Excellence (NICE) has published new guidelines for the management of patients with suspected and confirmed new coronavirus COVID-19The new guidelines include recommendations for disease management for patients with severe asthma, pneumonia, and rheumatic new coronary virus infectionindividuals with underlying diseases are more susceptible to the new coronavirus, so patient management guidelines have been updatedfor patients with severe asthma, NICE recommends that normal treatment continue and only attend the necessary appointmentsWHO also recommends that people with severe asthma regularly clean equipment, including masks and masksFor new coronavirus infections with rheumatic autoimmune, inflammatory and metabolic bone diseases, NICE recommends not stopping the drug altogether, but should seek advice on which drugs to continue to use and those that should be temporarily discontinuedNICE also provides medical staff with up-to-date advice on cough, fever, breathing difficulties and anxiety, as well as delusions and restlessness in PATIENTs with COVID-19this includes considering the use of paracetamol in people with fever, and advising people with mild coughs to take simple measures, such as avoiding lying on their backs, which can worsen the conditionIf the cough becomes more severe, health care providers may consider short-term use of codeine, codeine tabletphosphate or morphine sulfate oral solution
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
